loadpatents
name:-0.030858993530273
name:-0.026854038238525
name:-0.0016350746154785
SLAVIN; Shimon Patent Filings

SLAVIN; Shimon

Patent Applications and Registrations

Patent applications and USPTO patent grants for SLAVIN; Shimon.The latest application filed is for "methods, systems, and compositions for neuronal differentiation of multipotent stromal cells".

Company Profile
1.32.29
  • SLAVIN; Shimon - Tel-Aviv IL
  • SLAVIN; Shimon - Jerusalem IL
  • Slavin, Shimon - Ein Kerem IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods, Systems, And Compositions For Neuronal Differentiation Of Multipotent Stromal Cells
App 20200063135 - BRODIE; Chaya ;   et al.
2020-02-27
Methods, systems, and compositions for neuronal differentiation of multipotent stromal cells
Grant 10,421,961 - Brodie , et al. Sept
2019-09-24
MicroRNAs for the generation of astrocytes
Grant 10,034,902 - Brodie , et al. July 31, 2
2018-07-31
Generation of neural stem cells and motor neurons
Grant 9,803,175 - Brodie , et al. October 31, 2
2017-10-31
Tri-aryl Compounds And Compositions Comprising The Same
App 20170305836 - PRIEL; Esther ;   et al.
2017-10-26
Methods of generating oligodendrocytes and cell populations comprising same
Grant 9,783,781 - Slavin , et al. October 10, 2
2017-10-10
Telomerase activating compounds and methods of use thereof
Grant 9,670,139 - Gazit , et al. June 6, 2
2017-06-06
Tri-aryl compounds and compositions comprising the same
Grant 9,663,448 - Priel , et al. May 30, 2
2017-05-30
Synthetic analogs of sphingolipids
Grant 9,340,488 - Dagan , et al. May 17, 2
2016-05-17
Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasms
Grant 9,283,199 - Mardi , et al. March 15, 2
2016-03-15
Halogenated Aliphatic Carboxylic Acids, Oligomers And/or Polymers Thereof And Their Use In Devitalizing External And Internal Neoplasms
App 20160067198 - MARDI; Shalva ;   et al.
2016-03-10
Novel Synthetic Analogs Of Sphingolipids
App 20150073003 - DAGAN; Arie ;   et al.
2015-03-12
Synthetic analogs of sphingolipids
Grant 8,962,891 - Dagan , et al. February 24, 2
2015-02-24
MicroRNAS FOR THE GENERATION OF ASTROCYTES
App 20150037298 - Brodie; Chaya ;   et al.
2015-02-05
Generation Of Neural Stem Cells And Motor Neurons
App 20150037299 - Brodie; Chaya ;   et al.
2015-02-05
Mesenchymal Stem Cells For In Vitro Modeling And Cell-based Therapy Of Human Diseases And Banks Thereof
App 20150024966 - Brodie; Chaya ;   et al.
2015-01-22
Methods of treating tumors in immune-privileged sites
Grant 8,741,315 - Volovitz , et al. June 3, 2
2014-06-03
Telomerase Activating Compounds And Methods Of Use Thereof
App 20140142067 - GAZIT; Aviv ;   et al.
2014-05-22
Telomerase Activating Compounds And Methods Of Use Thereof
App 20140142068 - GAZIT; Aviv ;   et al.
2014-05-22
Tri-aryl Compounds And Compositions Comprising The Same
App 20140107336 - PRIEL; Esther ;   et al.
2014-04-17
Telomerase activating compounds and methods of use thereof
Grant 8,609,736 - Gazit , et al. December 17, 2
2013-12-17
Tri-aryl compounds and compositions comprising the same
Grant 8,604,245 - Priel , et al. December 10, 2
2013-12-10
Methods Of Generating Oligodendrocytes And Cell Populations Comprising Same
App 20130149288 - Slavin; Shimon ;   et al.
2013-06-13
Methods, Systems, And Compositions For Neuronal Differentiation Of Multipotent Stromal Cells
App 20120148550 - Brodie; Chaya ;   et al.
2012-06-14
Treating or preventing diabetes with cannabidiol
Grant 8,071,641 - Weiss , et al. December 6, 2
2011-12-06
Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy
Grant 8,066,989 - Lindhofer , et al. November 29, 2
2011-11-29
Halogenated Aliphatic Carboxylic Acids, Oligomers And/or Polymers Thereof And Their Use In Devitalizing External And Internal Neoplasms
App 20110052641 - Mardi; Shalva ;   et al.
2011-03-03
Novel Synthetic Analogs Of Sphingolipids
App 20110034542 - Dagan; Arie ;   et al.
2011-02-10
Synthetic Sphingolipid Analogs
App 20100311841 - Dagan; Arie ;   et al.
2010-12-09
Telomerase Activating Compounds And Methods Of Use Thereof
App 20100267667 - Gazit; Aviv ;   et al.
2010-10-21
Tri-aryl Compounds And Compositions Comprising The Same
App 20100256382 - Priel; Esther ;   et al.
2010-10-07
Methods Of Treating Tumors In Immune-privileged Sites
App 20100189750 - Volovitz; Ilan ;   et al.
2010-07-29
Therapeutic Uses Of Cannabidiol Compounds
App 20100158973 - Weiss; Lola ;   et al.
2010-06-24
Cells Isolated from Placenta, Device for Isolating Same, and Uses Thereof
App 20080213332 - Slavin; Shimon ;   et al.
2008-09-04
Methods of treatment of hematopoietic disorders
Grant 7,347,999 - Slavin , et al. March 25, 2
2008-03-25
Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation
App 20070264240 - Slavin; Shimon ;   et al.
2007-11-15
Treating or preventing diabetes with cannabidiol
App 20070099987 - Weiss; Lola ;   et al.
2007-05-03
Compositions comprising bone marrow cells, demineralized bone matrix and various site-reactive polymers for use in the induction of bone and cartilage formation
App 20060177387 - Slavin; Shimon ;   et al.
2006-08-10
Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy
App 20060115481 - Lindhofer; Horst ;   et al.
2006-06-01
Non-myeloablative tolerogenic treatment with tyrphostins
App 20040197335 - Slavin, Shimon ;   et al.
2004-10-07
Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation
App 20040170610 - Slavin, Shimon ;   et al.
2004-09-02
Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and their use in bone marrow transplantation
App 20040156834 - Slavin, Shimon ;   et al.
2004-08-12
Non-myeloablative/lymphoablative conditioning regimen to induce patient anti-donor unresponsiveness in stem cell transplantation
Grant 6,544,787 - Slavin April 8, 2
2003-04-08
Immunotherapy of cancer with allogeneic lymphocytes
App 20020176850 - Slavin, Shimon
2002-11-28
Non-myeloablative tolerogenic treatment
Grant 6,428,782 - Slavin , et al. August 6, 2
2002-08-06
Intracoronary stents containing quinazolinone derivatives
Grant 6,159,488 - Nagler , et al. December 12, 2
2000-12-12
Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
Grant 6,143,292 - Slavin November 7, 2
2000-11-07
Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
Grant 6,090,814 - Nagler , et al. July 18, 2
2000-07-18
Immunotherapy of cancer with allogeneic lymphocytes
Grant 5,928,639 - Slavin July 27, 1
1999-07-27
Immunotherapy of cancer with allogeneic lymphocytes
Grant 5,843,435 - Slavin December 1, 1
1998-12-01
Osteogenic growth polypeptides identified from regenerating bone marrow
Grant 5,461,034 - Rodan , et al. October 24, 1
1995-10-24
Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
Grant 5,449,678 - Pines , et al. September 12, 1
1995-09-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed